 |
|
|
| |
Integrase Strand Transfer Inhibitors are
Associated With Weight Gain in Women
|
| |
| |
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
Anne Marie Kerchberger, M Eng, AnandiN. Sheth, MD, MS, Christine D. Angert, BS, CyraChristina Mehta, PhD, MSPH, Nathan A.Summers, MD, IghoOfotokun, MD, MS, Deborah Gustafson, PhD, MS, Sheri Weiser, MD, MPH, SebleKassaye, MD, MS4, Deborah Konkle-Parker, PhD, FNP5,Anjali Sharma, MD,MS6, AdaoraAdimora, MD, MPH7, Hector Bolivar, MD8, Cecile D. Lahiri, MD,MS1 Emory University, Atlanta, GA, USA, SUNY Downstate Medical Center, Brooklyn, NY, USA, University of California San Francisco, San Francisco, CA, USA, 4Georgetown University, Washington, DC, USA, 5University of Mississippi, Jackson, MS, USA, 6Albert Einstein College of Medicine, Bronx, NY, USA, 7University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 8University of Miami, Miami, FL, USA
Plenary Talk: Obesity & Weight Gain on Antiretroviral Therapy - (03/11/19)
CABOTEGRAVIR IS NOT ASSOCIATED WITH WEIGHT GAIN IN HIV-NEGATIVE INDIVIDUALS - (03/06/19)
- MIDLIFE ADIPOSITY PREDICTS COGNITIVE DECLINE IN THE MULTICENTER AIDS COHORT STUDY (MACS) - (03/11/19)
- Pharmacogenetics of Weight Gain after Switch from Efavirenz to Integrase Inhibitors - (03/11/19)
- Weight Gain among Virally Suppressed Persons who Switch to INSTI-Based ART, The HIV Outpatient Study - (03/11/19)
- HIV-Cognitive Impairment/Obesity-Overweight-Exercise-Efavirenz-Age "OBESITY IS INDEPENDENTLY ASSOCIATED WITH NEUROCOGNITIVE DECLINE IN HIV".....16% had neurocognitive impairment (NCI) & 6% frailty at baseline (03/08/19)
- Memory and Learning Dysfunction with Integrase Strand Transfer Inhibitor Use (03/08/19)
- BRAIN VOLUMES CHANGES AFTER ABC/3TC + EFV OR TDF/FTC + ATV/r AS FIRST LINE ART
Themed Discussion slides / WEIGHT GAIN DURING ART:
Integrase Strand Transfer Inhibitors are Associated With Weight Gain in Women, Anne Marie Kerchberger http://www.croiwebcasts.org/console/player/41233?mediaType=slideVideo&&crd_fl=0&ssmsrq=1553348116791&ctms=5000&csmsrq=505
RISK FACTORS FOR EXCESS WEIGHT GAIN FOLLOWING SWITCH TO INTEGRASE INHIBITOR-BASED ART (ABSTRACT 669)
Jordan E Lake
University of Texas Health Science Center Houston, Houston, TX, USA
http://www.croiwebcasts.org/console/player/41230?mediaType=slideVideo&&crd_fl=0&ssmsrq=1553348173070&ctms=5000&csmsrq=5069
poster report - RISK FACTORS FOR EXCESS WEIGHT GAIN FOLLOWING SWITCH TO INTEGRASE INHIBITOR-BASED ART - (03/11/19)
GREATER WEIGHT GAIN AMONG TREATMENT-NAIVE PERSONS STARTING INTEGRASE INHIBITORS (ABSTRACT 670)
Kassem Bourgi
Indiana University School of Medicine, Indianapolis, IN, USA
http://www.croiwebcasts.org/console/player/41231?mediaType=slideVideo&&crd_fl=0&ssmsrq=1553348223275&ctms=5000&csmsrq=5048
poster report - GREATER WEIGHT GAIN AMONG TREATMENT-NAIVE PERSONS STARTING INTEGRASE INHIBITORS - (03/11/19)
WEIGHT GAIN DURING TREATMENT AMONG 3,468 TREATMENT-EXPERIENCED ADULTS WITH HIV (ABSTRACT 671)
Grace A. McComsey
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA
http://www.croiwebcasts.org/console/player/41232?mediaType=slideVideo&&crd_fl=0&ssmsrq=1553348266436&ctms=5000&csmsrq=5068
poster report - Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV - (03/11/19)
THE IMPACT OF WEIGHT GAIN AND SEX ON IMMUNE ACTIVATION FOLLOWING INITIATION OF ART (ABSTRACT 673)
Sara H Bares
University of Nebraska Medical Center, Omaha, NE, USA
http://www.croiwebcasts.org/console/player/41234?mediaType=slideVideo&&crd_fl=0&ssmsrq=1553348478446&ctms=5000&csmsrq=5052
poster report - The Impact of Weight Gain and Sex on Immune Activation Following Initiation of ART - (03/11/19)
QUESTIONS AND ANSWERS: discussion about is this an extension of LIPODYSTROPHY
http://www.croiwebcasts.org/console/player/41235?mediaType=audio&&crd_fl=0&ssmsrq=1553348825566&ctms=5000&csmsrq=5071
|
| |
|
|
|
|
|
